A farkon shekara, munyi magana game da a haƙƙin mallaka cewa Apple yayi rajista kuma hakan zai ba da damar sanin matakan sukari a cikin jini ta hanyar da ba ta shiga ba. Koyaya, a matsayin lambanta cewa hakan, wannan baya nufin Apple zai iya haɓaka aikin cikin ƙanƙanin lokaci (ko kuma yana da niyyar yin hakan), don haka da alama zaku yi aiki tare da kamfanoni na ɓangare na uku don ƙara wannan fasalin.
Sabon labarai da ya shafi yiwuwar Apple ciki har da mitar glucose a cikin jini ana samun sa ne a Rockley Photonics, wani kamfani a Burtaniya da ke tsara na'urori masu auna sigina don nazarin jinin mutum ta amfani da hasken infrared. Ana amfani da waɗannan firikwensin a kayan aikin likita da ba ka damar lura da matakan glucose na jini da na barasa.
Menene dangantakar Apple?
A cewar jaridar tangarahu, Rockley yana shirin zuwa jama'a a New York. Daga cikin duk takaddun da ya gabatar wa SEC, musamman wanda ya shafi dangantakar kuɗi, mun sami: Apple a matsayin daya daga cikin "kalilan kwastomominsa".
Rockley ya tabbatar da cewa manyan abokan cinikin biyu cikin 2020 suna wakiltar 100% na kuɗaɗen kamfanin da 99.6% a cikin 2019. Wannan jaridar ba ta iya sani shin Apple shine babban abokin ciniki ko na biyuKoyaya, duk abin da alama yana nuna cewa mai yiwuwa Apple yayi aiki tare da wannan kamfanin don gabatar da ma'aunin glucose na jini a cikin Apple Watch Series 8 wanda zai shiga kasuwa a 2022.
A cewar wannan jaridar, kamfanin yana da "yarjejeniyar samarwa da ci gaba" mai gudana tare da kamfanin, wanda yake fatan ci gaba da dogaro ga mafi yawan kudin shigar sa. A halin yanzu, yawancin yawancin kuɗaɗen shiga kuma daga kudaden injiniyoyi don aikin bunkasa samfur na gaba.